SOL Global Investments Corp.

CNSX:SOL Stock Report

Market Cap: CA$44.6m

SOL Global Investments Past Earnings Performance

Past criteria checks 0/6

SOL Global Investments's earnings have been declining at an average annual rate of -19.3%, while the Pharmaceuticals industry saw earnings growing at 45.6% annually. Revenues have been declining at an average rate of 24.3% per year.

Key information

-19.3%

Earnings growth rate

-17.9%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate-24.3%
Return on equity-362.6%
Net Margin46.4%
Last Earnings Update31 Aug 2024

Recent past performance updates

SOL Global Investments' (CSE:SOL) Problems Go Beyond Weak Profit

Apr 06
SOL Global Investments' (CSE:SOL) Problems Go Beyond Weak Profit

Recent updates

Does SOL Global Investments (CSE:SOL) Have A Healthy Balance Sheet?

May 03
Does SOL Global Investments (CSE:SOL) Have A Healthy Balance Sheet?

SOL Global Investments (CSE:SOL) Has A Pretty Healthy Balance Sheet

Jan 07
SOL Global Investments (CSE:SOL) Has A Pretty Healthy Balance Sheet

SOL Global Investments' (CSE:SOL) Problems Go Beyond Weak Profit

Apr 06
SOL Global Investments' (CSE:SOL) Problems Go Beyond Weak Profit

Revenue & Expenses Breakdown

How SOL Global Investments makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:SOL Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Aug 24-39-1820
31 May 24-43-2230
29 Feb 24-19-2540
30 Nov 23-32-3440
31 Aug 23-62-143110
31 May 23-67-148130
28 Feb 23-167-233170
30 Nov 22-236-297190
31 Aug 22-226-225480
31 May 22-203-275550
28 Feb 22-20-123680
30 Nov 21310159690
31 Aug 21396260360
31 May 21445367320
28 Feb 21384303160
30 Nov 2013998120
30 Nov 19-170-15680
30 Sep 19-125-151261
30 Jun 19-8554362
31 Mar 19-5295353
31 Dec 18-6483233
30 Sep 18-17139183
30 Jun 180-28153
31 Mar 180-26133
31 Dec 170-1963
30 Sep 170-1532
30 Jun 170-322
31 Mar 170-321
31 Dec 160-220
31 Mar 160-330

Quality Earnings: SOL is currently unprofitable.

Growing Profit Margin: SOL is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SOL is unprofitable, and losses have increased over the past 5 years at a rate of 19.3% per year.

Accelerating Growth: Unable to compare SOL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SOL is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-51.1%).


Return on Equity

High ROE: SOL has a negative Return on Equity (-362.55%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 17:32
End of Day Share Price 2024/12/24 00:00
Earnings2024/08/31
Annual Earnings2023/11/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SOL Global Investments Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution